Product Description

Gefitinib IP Tablets 250mg contains Gefitinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor used for the treatment of EGFR mutation-positive non-small cell lung cancer (NSCLC). It works by blocking signals that promote the growth and spread of cancer cells.

Product Overview

Product Name: Gefitinib IP Tablets 250mg

Generic Name: Gefitinib

Strength: 250mg

Form: Tablets

Pack Size: As per manufacturer packaging

Used For: Treatment of EGFR-positive non-small cell lung cancer

Prescription Required: Yes

Ingredients & How They Work

Each tablet contains Gefitinib 250mg, which inhibits the EGFR tyrosine kinase enzyme, helping to slow or stop the growth of cancer cells.

Key Benefits

• Helps treat EGFR-positive non-small cell lung cancer
• Slows the progression of cancer
• Targeted oral anticancer therapy
• Once-daily tablet formulation
• Supports long-term cancer management under specialist supervision

How to Use

Take exactly as prescribed by your healthcare provider. Swallow the tablet whole with water at the same time each day, with or without food.

Side Effects & Precautions

Possible Side Effects

• Acne-like skin rash
• Diarrhea
• Dry skin
• Fatigue
• Nausea

Precautions

• Use only under the supervision of an oncologist.
• Regular monitoring of liver function may be required.
• Report persistent cough or shortness of breath immediately.
• Inform your healthcare provider about all medications and supplements you are taking.

Storage Instructions

Store below 30°C in a cool, dry place away from direct sunlight and moisture.